Obeticholic acid, a synthetic FXR agonist, prevents hepatic inflammation and fibrosis in a novel mouse model of non-alcoholic steatohepatitis

被引：0
|
作者：
Goto, Toshihiro [1 ,2 ]
Itoh, Michiko [2 ]
Kanai, Sayaka [2 ]
Suganami, Takayoshi [3 ,4 ]
Ogawa, Yoshihiro [2 ,5 ]
机构：
[1] Sumitomo Dainippon Pharma Co Ltd, Drug Dev Res Labs, Osaka, Japan
[2] Tokyo Med & Dent Univ, Tokyo, Japan
[3] Nagoya Univ, Nagoya, Aichi 4648601, Japan
[4] JST PRESTO, Tokyo, Japan
[5] AMED CREST, Tokyo, Japan
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1609
引用
收藏
页码：797A / 798A
页数：2
相关论文
共 50 条
  • [1] TAUROURSODEOXYCHOLIC ACID ATTENUATES HEPATIC FIBROSIS IN A MOUSE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS
    Cho, E. J.
    Yu, S. J.
    Lee, J. -H.
    Yoon, J. -H.
    Lee, H. -S.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S485 - S485
  • [2] Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non-alcoholic steatohepatitis
    Kobayashi, Tomoki
    Kanno, Keishi
    Nguyen, Phuong Thao
    Sugiyama, Akiko
    Kawahara, Akihiro
    Otani, Yuichiro
    Kishikawa, Nobusuke
    Ito, Masanori
    Tazuma, Susumu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (12) : 2140 - 2150
  • [3] FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
    Len Verbeke
    Inge Mannaerts
    Robert Schierwagen
    Olivier Govaere
    Sabine Klein
    Ingrid Vander Elst
    Petra Windmolders
    Ricard Farre
    Mathias Wenes
    Massimiliano Mazzone
    Frederik Nevens
    Leo A. van Grunsven
    Jonel Trebicka
    Wim Laleman
    Scientific Reports, 6
  • [4] FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
    Verbeke, Len
    Mannaerts, Inge
    Schierwagen, Robert
    Govaere, Olivier
    Klein, Sabine
    Elst, Ingrid Vander
    Windmolders, Petra
    Farre, Ricard
    Wenes, Mathias
    Mazzone, Massimiliano
    Nevens, Frederik
    van Grunsven, Leo A.
    Trebicka, Jonel
    Laleman, Wim
    SCIENTIFIC REPORTS, 2016, 6
  • [5] REDUCTION OF ENDOPLASMIC RETICULUM STRESS PREVENTS HEPATIC FIBROSIS AND TUMORIGENESIS IN MOUSE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS
    Kon, K.
    Ikejima, K.
    Uchiyama, A.
    Yamashina, S.
    Watanabe, S.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 : 54A - 54A
  • [6] Trials of obeticholic acid for non-alcoholic steatohepatitis
    Musso, Giovanni
    Cassader, Maurizio
    Gambino, Roberto
    LANCET, 2015, 386 (9988): : 27 - 28
  • [7] A novel non-alcoholic steatohepatitis animal model featured with insulin resistance, hepatic inflammation and fibrosis
    Zhao, Jingmin
    Zhou, Guangde
    Li, Meirong
    Li, Wenshu
    Lue, Jiyun
    Xiong, Lu
    Liang, Li
    Zhao, Yulai
    Xu, Dongping
    Yu, Jun
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (11) : 1360 - 1371
  • [8] Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis
    Thomas Klein
    Masato Fujii
    Jan Sandel
    Yuichiro Shibazaki
    Kyoko Wakamatsu
    Michael Mark
    Hiroyuki Yoneyama
    Medical Molecular Morphology, 2014, 47 : 137 - 149
  • [9] Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis
    Klein, Thomas
    Fujii, Masato
    Sandel, Jan
    Shibazaki, Yuichiro
    Wakamatsu, Kyoko
    Mark, Michael
    Yoneyama, Hiroyuki
    MEDICAL MOLECULAR MORPHOLOGY, 2014, 47 (03) : 137 - 149
  • [10] Trials of obeticholic acid for non-alcoholic steatohepatitis Reply
    Neuschwander-Tetri, Brent A.
    Van Natta, Mark L.
    Tonascia, James
    Brunt, Elizabeth M.
    Kleiner, David E.
    LANCET, 2015, 386 (9988): : 28 - 29
12345